Qube Research & Technologies (QRT)
TNXP icon

Qube Research & Technologies (QRT)’s Tonix Pharmaceuticals TNXP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3
Closed -$210 – 4112
2024
Q2 		$210 Buy
+3
New +$1.36K ﹤0.01% 3385
2024
Q1 		– Hold
0
– – – 4390
2023
Q4 		– Hold
0
– – – 4248
2023
Q3 		– Hold
0
– – – 4014
2022
Q4 		– Sell
-1
Closed -$8K – 3001
2022
Q3 		$8K Hold
1
– – ﹤0.01% 2375
2022
Q2 		$25K Buy
+1
New +$73.8K ﹤0.01% 2241
2021
Q4 		– Sell
-1
Closed -$325K – 2972
2021
Q3 		$325K Buy
+1
New +$487K ﹤0.01% 1449

Other funds holding TNXP

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TNXP Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Tonix Pharmaceuticals (TNXP) in Q3 2024, closing a stake of 3 shares — an estimated $210 sold.

Qube Research & Technologies (QRT) first reported a position in TNXP in Q3 2021 and held it in 4 quarters. The position peaked at $325K in Q3 2021. 16 funds tracked by Wall St. Rank hold TNXP as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Tonix Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3 Tonix Pharmaceuticals shares in Q3 2024, an estimated $210.
  • Qube Research & Technologies (QRT) first reported a position in Tonix Pharmaceuticals in Q3 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Tonix Pharmaceuticals position peaked at $325K in Q3 2021.
  • 16 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.